An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype.
暂无分享,去创建一个
Peter Reiss | Hugo Tempelman | Andrew D Revell | Raph L Hamers | Ard I van Sighem | Brendan A Larder | B. Larder | J. Montaner | P. Reiss | R. Wood | A. van Sighem | A. Revell | R. Hamers | M. Nelson | Dechao Wang | H. Lane | Robin Wood | Julio S G Montaner | Mark Nelson | H. Tempelman | Dechao Wang | Carl Morrow | H Clifford Lane | C. Morrow
[1] B. Larder,et al. The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool , 2011, AIDS.
[2] S. Hammer,et al. The Relation between Baseline HIV Drug Resistance and Response to Antiretroviral Therapy: Re-Analysis of Retrospective and Prospective Studies Using a Standardized Data Analysis Plan , 2000, Antiviral therapy.
[3] Sabine Yerly,et al. Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis. , 2009, The Lancet. Infectious diseases.
[4] Brendan Larder,et al. The Development of Artificial Neural Networks to Predict Virological response to Combination HIV Therapy , 2007, Antiviral therapy.
[5] Lesley E Scott,et al. Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings. , 2010, The Journal of infectious diseases.
[6] A. Wensing,et al. Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings. , 2010, The Journal of antimicrobial chemotherapy.
[7] C. Leen,et al. British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.) , 2014, HIV medicine.
[8] R. Shafer,et al. 2014 Update of the drug resistance mutations in HIV-1. , 2014, Topics in antiviral medicine.
[9] A. Wensing,et al. An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes. , 2014, The Journal of antimicrobial chemotherapy.
[10] B. Gazzard,et al. Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experience. , 2011, AIDS patient care and STDs.
[11] Amalio Telenti,et al. Antiretroviral Treatment of Adult HIV Infection2010 Recommendations of the International AIDS Society–USA Panel , 2010 .
[12] J. J. Henning,et al. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.
[13] A. Wensing,et al. Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings. , 2013, The Journal of antimicrobial chemotherapy.
[14] Brendan Larder,et al. A Comparison of Three Computational Modelling Methods for the Prediction of Virological Response to Combination Hiv Therapy Author's Personal Copy , 2022 .